Table 1.
General characteristics of COPD patients.
| All patients, n = 30 | |
|---|---|
| Gender, n (%) | |
| Female | 7 (23.3) |
| Male | 23 (76.7) |
| Age, year, median (IQR) | 68 (11) |
| Tobaco (pack-year) | 50.8 ± 22.8 |
| Smoking status, n (%) | |
| Current smokers | 13 (43.3) |
| Ex-smokers | 16 (53.3) |
| Never smokers | 1 (3.3) |
| GOLD, n (%) | |
| A | 1 (3.3) |
| B | 7 (23.3) |
| C | 0 |
| D | 22 (73.3) |
| Obstruction, n (%) | |
| FEV1 ≥ 80% | 0 |
| FEV1 ≥ 50% | 11 (36.7) |
| FEV1 ≥ 30% | 13 (43.3) |
| FEV1 < 30%. | 6 (20) |
| Bronchodilator therapy, n (%) | |
| LAMA + LABA | 6 (20) |
| LAMA + LABA + ICS | 24 (60) |
| Home non-invasive ventilation, n (%) | 12 (40) |
| Home oxygen therapy, n (%) | 20 (66.7) |
| Comorbidity, n (%) | |
| Hypertension | 24 (80.0) |
| Diabetes | 9 (30.0) |
| Dyslipidemia | 18 (60.0) |
| Auricular fibrillation | 7 (23.3) |
| Ischemic heart disease | 9 (30.0) |
| Tuberculosis sequelae | 5 (16.7) |
| Gastroesophageal reflux disease | 5 (16.7) |
| Anxiety | 5 (16.7) |
| Depression | 4 (13.3) |
| Enphysema | 19 (63.3) |
| Height, cm, median (IQR) | 163 (6.50) |
| Weight, kg, mean ± SD | 61.6 ± 19.6 |
| BMI, Kg/m2, mean ± SD | 22.7 ± 7.9 |
| BMI, n (%) | |
| <18.5 Kg/m2 | 11 (36.7) |
| 18.5–25 kg/m2 | 5 (16.7) |
| 25–30 kg/m2 | 7 (23.3) |
| >30 kg/m2 | 7 (23.3) |
| NRS-2002, n (%) | |
| 1 | 6 (20.0) |
| 2 | 9 (30.0) |
| 3 | 9 (30.0) |
| 4 | 3 (10.0) |
| 5 | 3 (10.0) |
| Albumin, g/L, median (IQR) | 3.8 (0.8) |
| Total proteins, mean ± SD | 6.0 ± 0.6 |
| Vitamin D, ng/mL, mean ± SD | 8.3 ± 2.6 |
| MUAC, cm, mean ± SD | 23.5 ± 7.2 |
| TST, mm, mean ± SD | 7.6 ± 4.2 |
LAMA: long-acting muscarinic antagonist; LABA: long-acting beta2-agonist; ICS: inhaled corticosteroids; BMI: body mass index; MUAC: midupper arm circumference; TST: tricipital skinfold thickness.